<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, an acquired immunoglobulin associated with an increased tendency for <z:mp ids='MP_0005048'>thrombosis</z:mp>, has been linked to the occurrence of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> presumably related to in situ <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Cardioembolic cerebral ischemic events have rarely been reported </plain></SENT>
<SENT sid="2" pm="."><plain>We encountered 2 patients with focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, substantial mitral valvular masses, and a circulating <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In each, diagnostic evaluation supported a cardioembolic etiology </plain></SENT>
<SENT sid="4" pm="."><plain>These findings illustrate the need for evaluating patients with cerebral ischemic events for a cardioembolic source when a circulating <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> is present </plain></SENT>
</text></document>